Petros Pharmaceuticals Gross Margin Growth & History (PTPI)

Petros Pharmaceuticals's gross margin was 76.28% for fiscal 2024.

View full Petros Pharmaceuticals company overview

Petros Pharmaceuticals annual gross margin history

Petros Pharmaceuticals annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20242024-12-3176.28%+4.29 pp
20232023-12-3171.98%+10.19 pp
20222022-12-3161.79%−17.73 pp
20212021-12-3179.52%+21.85 pp
20202020-12-3157.67%

Petros Pharmaceuticals gross margin trends

Across the available reported history, Petros Pharmaceuticals's gross margin increased from 71.98% to 76.28%, a change of +4.29 percentage points. The latest reported quarter, Q4 2024, shows 63.50%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Petros Pharmaceuticals filings at SEC.gov ↗